Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001258 · ClinicalTrials.gov registry record
Studies of Frontal Lobe Brain Functioning in Schizophrenia
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 1,039
- Enrollment target
NCT00001258: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00001258 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,039 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001258 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 1,039 participants
- Enrollment target
Study Summary
The purpose of this study is to use brain imaging technology to investigate the role of the frontal lobe of the brain in the thinking of individuals with schizophrenia and other neuropsychiatric disorders and healthy volunteers. Participants in this study will undergo a positron emission tomography (PET) scan of the brain while performing neuropsychological tests. Some of the tests involve cognitive operations that depend upon the frontal cortex. Interactions between frontal lobe activation, cognitive behavior, and neuropharmacology will be assessed by measuring regional cerebral blood flow (rCBF) during treatment with drugs that may affect frontal lobe physiology....
Primary Outcome
ongoing
Interventions
- DRUG Oxygen-15 Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,039 participants |
| Start Date | 1993-11-26 |
What the finished NCT00001258 record still lists
NCT00001258 is an observational study that tracks outcomes without assigning an intervention. Its 1,039 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Oxygen-15 Water is the first listed.
NCT00001258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001258 about?
NCT00001258 is a clinical study titled "Studies of Frontal Lobe Brain Functioning in Schizophrenia". The purpose of this study is to use brain imaging technology to investigate the role of the frontal lobe of the brain in the thinking of individuals with schizophrenia and other neuropsychiatric disorders and healthy volunteers. Participants in this study will undergo a positron emission tomography...
What is the current status of trial NCT00001258?
This trial is currently completed. The enrollment target is 1,039 participants. The study started on 1993-11-26.
What interventions are being tested in trial NCT00001258?
The interventions under investigation include: Oxygen-15 Water (DRUG).
Who is sponsoring clinical trial NCT00001258?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- NCT07345767 · 1,038 participants · NA
Hypknowledge Nationwide Sleep Extension
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI